1021. Bringing Neuroscience to the Clinic: Patients’ Perceived Value of Trainee-Delivered Neuroscience Content in an Intensive Outpatient Program for Substance Use Disorders

2017 ◽  
Vol 81 (10) ◽  
pp. S412-S413
Author(s):  
Jared Moreines ◽  
Jared Florance ◽  
Jody Glance ◽  
Melissa Arbuckle ◽  
David Ross ◽  
...  
Author(s):  
Rachel H. Salk ◽  
Eydie L. Moses-Kolko ◽  
Carla D. Chugani ◽  
Susan Mastruserio ◽  
Erin Wentroble ◽  
...  

2016 ◽  
Vol 44 (4) ◽  
pp. 281-289 ◽  
Author(s):  
Jeanne L. Jensma

This article reports the findings of an outcome study done at ALONGSIDE, a counseling-focused retreat center that offers three-week intensive outpatient programs for Christian leaders, the majority of whom are missionaries. Repeated measures research utilized the Outcome Questionnaire - 45.2 (OQ-45.2) to explore whether or not clients participating in the three-week intensive outpatient program realized significant clinical progress and whether or not therapeutic gains were retained after the conclusion of the program. Missionaries and other Christian leaders took the inventory online a month before coming to ALONGSIDE, upon arrival, at the end of the three-week program, and three months after the program concluded. The results indicated that a month of time before arrival did not bring about a significant reduction in symptomatology among the 191 subjects, but three weeks of ALONGSIDE's intensive outpatient program resulted in significant clinical improvement which remained when the inventory was taken again three months post-program. This suggests that in a fairly short period of time, an intensive outpatient program consisting of psycho-education, group psychotherapy, and individual and/or marital counseling within a milieu of intentional Christian community can be a highly effective model for promoting enduring psychological healing.


2017 ◽  
Vol 26 (8) ◽  
pp. 780-787 ◽  
Author(s):  
James Mckowen ◽  
Nicholas Carrellas ◽  
Courtney Zulauf ◽  
Emin Nalan Ward ◽  
Ronna Fried ◽  
...  

Author(s):  
Sheila A. M. Rauch ◽  
Barbara O. Rothbaum ◽  
Erin R. Smith ◽  
Edna B. Foa

This therapist guide presents the scaffold and structure for the Prolonged Exposure-Intensive Outpatient Program (PE-IOP). The program is focused on exposure as provided through individual imaginal exposure and group in vivo exposure. The format presented is based primarily on the model used in the Emory Healthcare Veterans Program (EHVP), but this chapter provides a focus on the most common variations in program design with a discussion of how to decide between the different potential variations. Relevant inclusions and exclusions are presented along with rationales.


2020 ◽  
Vol 28 (6) ◽  
pp. 789-795
Author(s):  
Dan V. Blalock ◽  
Daniel Le Grange ◽  
Craig Johnson ◽  
Alan Duffy ◽  
Jamie Manwaring ◽  
...  

SLEEP ◽  
2020 ◽  
Vol 43 (Supplement_1) ◽  
pp. A422-A422
Author(s):  
A K Wilkerson ◽  
D J Taylor ◽  
G L Sahlem ◽  
R O Simmons ◽  
A Russell ◽  
...  

Abstract Introduction Previous studies have shown that sleep problems are commonly reported during treatment for substance use disorders (SUDs) and sleep complaints have been linked to subsequent relapse. However, most of these findings were in well-controlled clinical trials and may not generalize to the public. Little is known about the natural progression of sleep complaints during treatment in community clinics, the most common treatment approach for SUDs. The aim of this study is to longitudinally assess prevalence of clinically significant sleep disturbance at baseline and post-treatment in a community-based intensive outpatient (IOP) SUD treatment program using a multi-method approach with well-validated measures of sleep. Methods Adults beginning IOP SUD treatment completed the Pittsburgh Sleep Quality Index (PSQI), Insomnia Severity Index (ISI), Nightmare Disorder index (NDI), and one week of actigraphy and sleep diaries. Measures were repeated following treatment (approximately 5 weeks later). Results Preliminary analyses on 21 adults who have been enrolled thus far revealed 85.6% of participants experienced sleep disturbance (PSQI > 5) at baseline. 28.5% of participants reached cutoff for moderate-to-severe insomnia symptoms (ISI > 15) and 42.9% reported nightmares more than once per week. Sleep parameters taken from actigraphy and sleep diaries revealed mean sleep efficiency was 77.5% (TST M = 6.2 hours; TIB M = 7.9 hours). These variables did not improve from baseline to post-treatment. Further, most measures indicated a worsening of sleep, though this did not reach significance (all ps > .05). Conclusion This preliminary data show a high prevalence of self-reported sleep complaints and objectively measured poor sleep efficiency that do not improve over the course of treatment. Data collection is ongoing and expected to at least double. More robust analyses, including differences between SUD type (e.g., cannabis vs. opioid) and relationship to relapse at post-treatment, will then be completed. Support K12DA031794


Sign in / Sign up

Export Citation Format

Share Document